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Abstract Elderly people whose daily activities have
declined due to a cerebrovascular disorder may suffer
from dysphagia and may find oral hygiene difficult.
Therefore, it is important to establish an effective
therapy for the underlying cerebrovascular disorder.
Dedifferentiated fat cells (DFAT) were obtained from
mature adipocytes isolated from human buccal adi-
pose pads in a ceiling culture. DFAT expressed the
neural markers Nestin and SOX2. Flow cytometric
analysis revealed that the cells had properties similar
to mesenchymal stem cells. Although the transplan-
tation of DFAT did not change the infarction area and
volume ratios in a murine cerebral infarction model,
functional recovery was observed in behavioral tests.
Furthermore, DFAT administered to mice were later
detected in cerebral infarctions. It therefore appears
that transplanted DFAT affect the brain after infarc-
tion and contribute to the promotion of functional
recovery. This finding may provide new cell replace-
ment therapy options for treating disorders of the
central nervous system.
Keywords Cerebrovascular disorder 
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Introduction
Elderly people whose daily activities have declined
due to a cerebrovascular disorder may suffer from
dysphagia and may find oral hygiene difficult. This
may lead to an increase in the occurrence of aspiration
pneumonia and mortality (Umarova et al. 2007;
Rochester and Mohsenin 2002). Therefore, it is
important to establish an effective therapy for the
underlying cerebrovascular disorder. Cardiovascular
regeneration therapy using stem cells for cerebral
infarction has gained attention in recent years.
Because many patients with cerebral infarction are
elderly with other concurrent cardiovascular condi-
tions such as high blood pressure and abnormal heart
rhythm, invasive sampling procedures to harvest cells
for transplantation from such patients should be
avoided as much as possible.
Bone marrow stromal cells (BMSC) are mesenchy-
mal stem cells (MSC) that have been reported to
differentiate not only into ectoderm-derived bone,
cartilage, and fat cells but also into endoderm-derived
nerve cells. The effectiveness of central nervous
system regeneration using BMSC has been noted in
animal experiments (Kurozumi et al. 2004, 2005) and
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clinical research (Bang et al. 2005). However, lumbar
puncture, which is required to extract BMSC, is
sometimes invasive; thus, a non-invasive method may
be recommended. In contrast, adipose stem cells
(ASC), which are MSC-like BMSC established from
adipose tissue, are good candidates for clinical use as
transplanted cells due to minimal invasiveness. The
utility of the transplantation of ASC for neuronal
regeneration in the central nervous system has been
reported in animal studies (Gutie´rrez-Ferna´ndez et al.
2013b; Ikegame et al. 2011), and clinical research is
currently underway (Gutie´rrez-Ferna´ndez et al.
2013a). However, both BMSC and ASC derived from
the bone marrow or fatty tissue exhibit non-uniform
cell populations. With regard to safety in clinical
applications, it is desirable to use high-purity cell
populations (uniform cells) as cells for transplantation.
Alternatively, dedifferentiated fat cells (DFAT),
which can be obtained from mature fat tissue by
ceiling culture method, show uniform cell population
(Ohta et al. 2008). Ohta et al. also noted that neuronal
markers are expressed in primary undifferentiated
DFAT suggesting that these cells essentially have
neural traits. Subsequently, the transplantation of
DFAT has been reported to show the recovery of
motor function of the hind limbs in a rat spinal cord
injury model, indicating the efficacy of the transplan-
tation of DFAT in the central nervous system.
However, the effects in a cerebral infarction model
have not yet been reported. We hypothesized that the
transplantation of DFAT in an animal model of
cerebral infarction has a neural regenerative effect
on cerebral infarction. Thus, the purpose of this study
was to evaluate the effect of DFAT transplantation on
cerebral infarction both morphologically and func-
tionally in a reproducible and simple model of cerebral
infarction in mice.
Materials and methods
Animal studies
We used 5-week-old male C.B-17/Icr-?/?Jcl mice
(CLEA Japan, Inc., Tokyo, Japan). The mean weight is
27.5 g. Treatment of all animals was conducted in
compliance with the guidelines of Osaka Dental
University Animal Experiment Committee and
‘‘Guidelines on Animal Protection, Welfare and
Use’’ of the Biological Science Research Committee.
Animals were provided with food and water ad libitum
and were maintained in an environment with a 12-h
light–dark cycle. We made every effort to minimize
their pain and the number of animals used.
Isolation and ceiling culture of DFAT
We collected human buccal adipose pads from a
woman (27 years old) who had undergone oral
maxillofacial surgery at Osaka Dental University
Hospital. All research procedures were approved by
the Medical Ethics Committee of Osaka Dental
University (approval number 110,828). We isolated
DFAT using the ceiling cultivation method described
by Kishimoto et al. (2014). Briefly, approximately 3 g
of thinly cut buccal adipose pads were processed in
0.1% (w/v) collagenase solution (collagenase type I;
Wako Pure Chemical, Osaka, Japan) at 37 C for 1 h.
The cell suspension was then filtered through 150- and
250-lm nylon meshes to eliminate unwanted cells and
tissue. After filtration, the suspension was centrifuged
at 1000 rpm for 4 min and the floating layer of oil
droplets containing adipose cells was collected. Iso-
lated adipocytes were seeded into 25-cm2 flasks
(SUMILON; Sumitomo Bakelite Co. Ltd., Tokyo,
Japan), fully filled with a medium that contained an
antibiotic–antimycotic (10,000 U/ml penicillin,
10,000 lg/ml streptomycin, and 25 lg/ml ampho-
tericin B; Nacalai Tesque, Kyoto, Japan) and 20% v/v
fetal bovine serum (FBS; lot number AYD62671;
HyClone Laboratories Inc., Logan, UT, USA), and
then added to Dulbecco’s modified Eagle’s medium
(DMEM; control condition medium; Nacalai Tesque).
Flasks were placed with the culture surface facing
upward, and lipid droplets including floating adipose
cells were incubated at 37 C in 5% CO2 to allow for
the adhesion of cells to the inner surface of the flask
ceiling. After 7 days, the medium was removed and
the flask was turned over. Thereafter, normal cell
culture was conducted. The medium was replaced
every 4 days (Fig. 1). When the cells reached conflu-
ence, they were removed with 0.25% trypsin/1 mM
EDTA (Thermo Scientific, Rochester, NY, USA) and
placed into 75-cm2 flasks (SUMILON; Sumitomo
Bakelite Co. Ltd.) (passage 1). Then, for immunohis-
tochemical staining, DFAT were placed in 12-well
plates (AGC Techno Glass Co. Ltd., Tokyo, Japan).
After culturing in control medium for 12 days, the
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cells were verified for confluence. Cultured DFAT
were fixed in 4% paraformaldehyde/phosphate-buf-
fered saline (pH 7.4). Immunohistochemical staining
was performed with anti-Nestin antibodies (1:200;
Merck Millipore, Darmstadt, Germany), anti-SOX2
antibodies (1:100; Merck Millipore), and CD45 anti-
body (R&D Systems, Minneapolis, MN, USA).
Flow cytometric analysis
Third-passage DFAT were analyzed for cell surface
antigens. The number of cells per assay was
3.5 9 105. A human mesenchymal stem cell marker
antibody panel (R&D Systems) was used for the
primary antibodies. The antibodies employed were
STRO-1, CD19, CD44, CD45, CD90, CD105, CD105,
CD146, and CD166. Reaction with primary antibodies
occurred at room temperature for 30 min, after which
the cells were washed. Alexa Fluor 488-conjugated
IgG and IgM antibodies were used as secondary
antibodies and the cells were incubated at room
temperature in the dark for 30 min. ABD LSR
FortesssaTM X-20 flow cytometer (BD Biosciences,
Franklin Lakes, NJ, USA) was employed for flow
cytometric analysis. Data analysis was performed with
a BD FACStation (Tree Star, Ashland, OR, USA).
Differentiation of DFAT into neural cells
Based on previous reports (Nakagomi et al. 2009a, b;
Reynolds and Weiss 1992; Nakata et al. 2017), we
conducted differentiation of nerve cells guided by
DFAT. DFAT (third passage) were placed in 60-mm-
diameter, poly-D-lysine-coated dishes (Thermo Scien-
tific) and cultured in DMEM/F12 (Invitrogen, Carls-
bad, CA, USA) with epidermal growth factor (EGF;
20 ng/ml; Peprotech, Rocky Hill, NJ, USA) and
fibroblast growth factor-basic (FGF; 20 ng/ml; Pepro-
tech) for 3 weeks. Formed neurosphere-like cell
clusters were placed on top of poly-L-lysine-coated
(0.05%) glass coverslips (Matsunami Glass Ind., Ltd.,
Osaka, Japan). The glass coverslips with neurosphere-
like cell clusters were placed in 35-mm-diameter
dishes (Thermo Scientific) and incubated in neu-
robasal medium (Neural Condition Medium; Invitro-
gen) containing retinoic acid (0.06 mg/ml; Sigma-
Aldrich, St. Louis, MO, USA) and B-27 supplement
(Invitrogen) for 1 week.
Next, clusters of DFAT were subjected to antibod-
ies against TuJ1 (1:1000; Stemcell Technologies,
Vancouver, BC, Canada) for immunohistochemical
staining. The Alexa Fluor 488-conjugated secondary
antibodies (1:500; Molecular Probes, Eugene, OR,
USA) stained green. The nuclei were stained with 40,6-
diamidino-2-phenylindole (DAPI; 1:1000; Kirkegaard
& Perry Laboratories, Gaithersburg, MD, USA). After
staining, cells were observed with a fluorescence
microscope (Olympus DP71; Olympus Inc., Tokyo,
Japan).
Fig. 1 Isolation and celling
culture of human DFAT
from human buccal adipose
pads. In the ceiling
cultivation method, the cells
reached confluence after
about 1 week. Then the
medium was removed and
the flask was turned over,
normal cell culture was
performed
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Induction of focal cerebral ischemia and cell
transplantation
Permanent cerebral ischemia was induced by electro-
surgical occlusion of the left middle cerebral artery of
male mice as previously reported (Taguchi et al.
2010). Briefly, while the mice were inhaling sevoflu-
rane, the left middle cerebral artery (MCA) was
isolated and a cut was made immediately before MCA
crossed the olfactory tube (distal M1 part). The
resulting area of cerebral infarction in mice is highly
reproducible and has been shown to be limited to the
ipsilateral cerebral cortex (Nakagomi et al. 2009a, b;
Taguchi et al. 2004, 2007). Two days after inducing
cerebral ischemia, 30 ll of phosphate-buffered saline
(PBS) (n = 6) or 30 ll of PBS containing 5 9 105
DFAT (after third passage) (n = 10) was injected
intravenously into the tail vein. The sham control
group contained mice (n = 4) that were subjected to
intravenous administration of 30 lL PBS 2 days after
drilling the hole in the skull. These mice did not
develop cerebral infarction. To assess functional
behavior, we conducted behavioral tests for 4 weeks.
Four weeks after cerebral infarction, mice were
euthanized to remove their brain tissue and the tissue
was fixed in 4% paraformaldehyde/PBS. Images of the
whole brain from the parietal side were taken with an
Olympus szx12 microscope (Olympus Inc.). The
image analysis software Picworks7c (Grambel Preci-
sion Inc., Tokyo, Japan) was used. Brain surface areas
were measured using The National Institutes of Health
ImageJ software (Version 1.51). The infarct side intact
cortical surface area was the size of the left cerebral
cortex excluding the cerebral infarction site, and the
ratio of the infarct side intact cortical surface area to
the contralateral cortical (non-infarct side) surface
area was calculated. Following immersion and enrich-
ment in sucrose for 3 days, brain tissues were
sectioned into 20-lm-thick specimens using a cryo-
stat. Images of these specimens were taken with a BZ-
X710 microscope (Keyence Corp., Osaka, Japan). The
image analysis software was BX-X Analyzer (Key-
ence Corp.). Tissue area was measured using ImageJ
software. The infarct side intact cortical volume
represented the quantity of the left cerebral cortex
excluding the cerebral infarction site, and the ratio of
the infarct side intact cortical volume to the contralat-
eral cortical (non-infarct side) volume was calculated.
Behavioral tests
Water maze learning (WM) was used to assess
motivation. The details of this test are presented
below. We used a shallow cylindrical pool (internal
diameter 95 cm and height 30 cm) that was fixed
horizontally on an installation base of height 35 cm.
The platform was a disk of 10 cm in diameter and
1 cm in thickness that was attached to a pedestal, with
a total height of 21 cm. The platform surface was
placed at the center of any of the four fan-shaped
quadrants into which the pool was divided. The
shortest distance between the platform edge and the
inner wall of the pool was 15 cm. The water level on
the surface of the platform was approximately 5 mm.
Water was made opaque by the addition of titanium
dioxide, and the temperature was maintained at
24 C ± 1 C. Each mouse was subjected to five
trials per day for 5 consecutive days. In each trial, mice
were introduced to a random quadrant where the
platform was not located. The mouse was placed with
its head turned toward the wall and allowed to swim
toward the platform. The time until both forelimbs
contacted the platform was measured. The mouse was
held for 10 s after reaching the platform. If the mouse
did not reach the platform within 60 s after introduc-
tion to the pool, the researcher placed it onto the
platform and held it there for 10 s. In such cases,
escape latency was recorded as 60 s. The interval
between trials was 30 s. On the day following the last
day of acquisition training, a trial test was conducted
by releasing the mouse into the pool from which the
platform was removed.
The levels of sensation, perception, and pain
susceptibility were evaluated using the hot plate test
(HP). An experimental apparatus for mouse hot plate
testing (MK-350B: Muromachi Kikai Co., Ltd. Tokyo,
Japan) was used. A cylinder made of transparent
acrylic (25 cm high) surrounded the hot plate to
prevent the mouse from escaping. The surface tem-
perature of the hot plate was adjusted in 2 C intervals
in the range of 50–58 C, to set five temperature
conditions. All mice were subjected to each temper-
ature condition, and measurements of their reactions
were made and recorded in ascending order from low-
to high-temperature conditions. The interval between
trials was 10 min. In each trial, the mouse was exposed
to the hot plate surface and the time until it tried to
jump away from this surface was noted.
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Measurements were terminated at 20 s, and in the
event a reaction did not occur, the time was recorded
as 20 s. Motor function was evaluated using the wire
hang test (WH). A wire plate in which metal wires of
3 mm thickness were arranged in a grid at 1-cm
intervals was used. This plate was mounted on the
ceiling of a rectangular glass tank (walls of 30 cm in
height). Each mouse was subjected twice to wire
hanging for 1 min. In each trial, the mouse was held
horizontally on the wire plate for approximately 10 s.
After confirming that the limbs of the mouse were
gripping the wires, the wire plate was inverted 180
and attached to the ceiling of the tank. The time until
the mouse dropped to the floor was measured. The
measurement was terminated at 180 s and, in the event
that the mouse had not dropped to the floor, this was
recorded as 180 s.
Antidepressant emotions were evaluated using the
forced swimming test (FS). An experimental animal
activity monitoring system (Supermex; Muromachi
Kikai Co. Ltd.) and control software (CompACT FSS2
ver2; Muromachi Kikai Co. Ltd.) were employed. The
apparatus was a soundproofed, rectangular chamber
[40 9 60 9 40 cm (width 9 length 9 height)] fitted
with an infrared sensor (Supermex sensor; Muromachi
Kikai Co. Ltd.) in the middle of the ceiling. Directly
beneath the infrared sensor inside the chamber, a
plastic cylindrical tank (diameter 18 cm, height
29 cm) was filled to a depth of 15 cm with water
(24 ± 1 C). The chamber interior was equipped with
white LED and, when illuminated, the amount of light
was 150 lx in tank water. In addition, a small
ventilation fan was attached to the rear of the chamber
to provide ventilation and mask noise. Sound pressure
was approximately 45 dB(C) at the floor in the center
of the chamber. Each mouse was subjected to 6 min of
forced swimming and individually released into the
cylindrical water tank. All reactions arising from
forced swimming were detected every second and
comparatively quantified, and the total was considered
as the amount of activity. Further, there was visual
assessment every second, and if the movements were
less than the reference value of ‘‘there was no reaction
other than floating on the water,’’ it was defined as an
immobile state. The total time spent immobile was
also calculated. Despair and depression-like behaviors
were assessed using the tail suspension test (TS). An
experimental animal activity monitoring system (Su-
permex) and control software CompACT FSS2 ver2
(Muromachi Kikai Co. Ltd.) were employed. The
apparatus was a soundproofed, rectangular chamber
[40 9 60 9 40 cm (width 9 length 9 height)] fitted
with an infrared sensor (Supermex sensor) in the
middle of the ceiling. Directly beneath the infrared
sensor in the chamber, a plastic rod for hanging the
mouse was horizontally fixed at a height of 30 cm
from the floor. During the experiment, a compact
extractor fan mounted on the chamber wall constantly
provided ventilation, and the sound was used as
masking noise. Sound pressure was approximately
45 dB(C) at the floor in the center of the chamber.
Each mouse was hung for 6 min from the abovemen-
tioned plastic rod with a metal hook attached to
perforated plastic tape wrapped 2 cm from the tip of
the tail. The distance between the head of the mouse
and the floor of the soundproof chamber was approx-
imately 10 cm. The tail suspension procedure detected
the subject’s struggle reaction every second and
activity intensity was quantified each minute.
Tracking of transplanted cells
A Vybrant Multicolor Cell-Labeling Kit (Dil) (Molec-
ular Probes Inc., OR, USA) was used to label 5 9 105
DFAT (after the third passage). Two days after
inducing cerebral infarction, labeled cells were
administered intravenously to mice (n = 4). On the
following day, mice were deeply anesthetized with
pentobarbital (50 mg/kg). Then, after euthanasia by
cervical dislocation, the spleen, lungs, liver, and brain
were removed. Each organ was fixed in 4%
paraformaldehyde/PBS. Specimens of 12 lm thick-
ness were made using a cryostat. Images were taken
with a fluorescence microscope (Olympus DP12;
Olympus).
Statistical analysis
The results are shown as mean ± SEM. To analyze
brain area, volume, and ratios, SPSS Ver12.0 for
Windows (SPSS Inc., Chicago, IL, USA) was used and
the Kruskal–Wallis test was employed for statistical
analysis. For behavioral tests, analysis of variance was
performed and multiple comparisons were statistically
analyzed by Fisher’s least significant difference test. If
asymptotic significance probability P\ 0.05 was met,
we considered the difference to be statistically
significant.
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Results
Characteristics of DFAT
DFAT cultured in control condition medium resem-
bled fibroblastic cells at the whole-cell level. Expres-
sion of Nestin and SOX2, but not CD45, was observed
in them using immunohistochemistry. Flow cytometry
indicated that, as cell surface markers, STRO-1,
CD44, CD90, CD105, and CD146 were expressed,
but CD19, CD45, and CD106 were not (Fig. 2).
DFAT formed clumps when cultivated as sus-
pended culture in Petri dishes with neural condition
medium. When changing to the neural condition
medium, the clumps grew for 4–5 days, and then did
not subsequently show any changes in size. Culturing
clumps on the surface of poly-L-lysine-coated (0.05%)
glass coverslips in neural condition medium culmi-
nated in differentiation into dendritic-like cells.
Immunohistochemical staining resulted in TuJ1
expression (Fig. 3).
Utility of the transplantation of DFAT into mice
with cerebral infarction
Nine out of 10 mice transplanted with DFAT survived
for 4 weeks. A total of eight mice were analyzed after
the exclusion of one mouse in which cerebral infarc-
tion had not been successfully induced from among
the group administered cells. Results from behavioral
evaluations such as WH, WM, and TS showed no
difference between mice in the cerebral infarction
group transplanted with DFAT compared with the
non-transplant group. HP of 56 C indicated a differ-
ence between mice in the cerebral infarction group
transplanted with DFAT and the PBS-administered
group. In addition, FS at 1 min exhibited a difference
between mice in the cerebral infarction group trans-
planted with DFAT and those in the PBS-administered
group (Fig. 4). The infarct side intact cortical surface
area (Fig. 5a) and volume (Fig. 5d) and ratios
(Fig. 5c, f) were not significantly different between
the DFAT-transplant and PBS-administered groups.
On the other hand, there was a significant difference
between the DFAT-transplant group and the sham
Fig. 2 DFAT characteristics. DFAT culture condition after
5 days (a), 9 days (b), and 13 days (c). Immunohistochemical
staining of DFAT (d–f). Expression of Nestin (d) and SOX2
(e) appear green, but CD45 is not expressed (f). The nucleus is
stained blue. Purple open histograms represent antibody isotype
controls, and blue closed histograms represent a sample stained
with specific antibodies. Scale bar = 100 lm (a–c); 50 lm (d–
f)
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group, and between the PBS-administered group and
the sham group (Fig. 5a, c, d, f). Labeled DFAT was
observed in the brain, spleen, liver, and lung (Fig. 5g–
j).
In HP, at a high temperature of 56 C, mice
responded more sensitively in the cerebral infarction
group transplanted with DFAT than those in the
cerebral infarction PBS-administered group. In FS,
mice in the cerebral infarction group transplanted with
DFAT exhibited shorter immobility time than those in
the cerebral infarction PBS-administered group.
Discussion
In this study, we analyzed cells acquired using the
ceiling culture method by flow cytometry. The results
from analysis of surface antigens of DFAT were
consistent with those reported previously (Matsumoto
et al. 2008; Patricia et al. 2002). Furthermore, CD105,
CD73, and CD90 were expressed in MSC; CD45,
CD34, CD14, CD11b, CD79alpha, or CD19 were not
expressed in MSC (Dominici et al. 2006). DFAT used
in this research expressed CD90 and CD105, but not
CD19 or CD45. Thus, it appears that DFAT have
similar characteristics to MSC.
DFAT cultured in control condition medium
expressed Nestin and SOX2, both are neural stem cell
markers. Ohta et al. (2008) have reported that Nestin
and GFAP, an astrocyte marker, are expressed even in
DFAT that do not show the differentiation. Poloni
et al. (2015) also have shown that DFAT forming
neurosphere-like cell clusters differentiate into neural
cells expressing Tuj1, NSE, MAP2, and GFAP. We
found in this study that DFAT-derived neurosphere-
like cell clusters culturing in neurobasal medium
differentiated into neural cells forming dendrite-like
spines. In addition, these cells were shown to express
Tuj1, a marker of neural cells. Therefore, it appears
that our DFAT underwent neural differentiation
in vitro.
We previously conducted a research on bone tissue
regeneration using DFAT, in which DFAT have
expressed osteoblast markers such as alkaline phos-
phatase (ALP) osteocalcin (OCN) and calcium simi-
larly to BMSC (Sakamoto et al. 2015). Expression of
osteoblast markers (ALP, OCN, and calcium) by
DFAT also have been shown in another report
(Kishimoto et al. 2014). These studies have suggested
that DFAT would have multi-potential to differentiate
into cells of various tissues and would be useful for
several tissue regenerations.
Unfortunately, the current study showed no signif-
icant differences in the infarct side intact cortex area or
volume between DFAT and the PBS-administered
group of murine cerebral infarction model. Ikegame
et al. (2011) intravenously administered MSC sooner
after MCA reperfusion using a transient cerebral
infarction mouse model, and mice receiving MSC
showed a reduction in infarction volume. On the other
Fig. 3 Neural differentiation of DFAT. Suspended cultures of
DFAT form clumps (a). When grown on a cell culture adhesion
plate, dendritic-like protrusions (yellow arrow) are observed (b).
Immunohistochemical staining of the dendritic-like protrusions
yields TuJ1 expression (c)
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hand, Gutie´rrez-Ferna´ndez et al. reported that func-
tional recovery was observed after intravenous admin-
istration of MSC to a permanent infarct rat model.
However, no decrease in the cerebral infarction
volume was observed. Although no detailed mecha-
nism was mentioned, it was speculated that the fact
that the MCA reperfusion could not be performed in
the permanent infarction model was the reason why a
reduction in the cerebral infarction volume was not
observed (Gutie´rrez-Ferna´ndez et al. 2013b). In this
study, we also used a permanent infarction model so
that reperfusion was not necessary. However, this may
have led to the absence of a decrease in the cerebral
infarct surface area and volume. Because mice in the
sham group did not develop cerebral infarction, we
speculate that the infarct side intact cortical surface
area, volume, and ratio in the sham group were
significantly larger than the PBS-administered or
DFAT-transplant groups.
Behavioral tests showed significant differences in
HP and FS. It is surmised that cell transplantation
improved sensory, perceptual, pain sensitivity, and
depressant behavior. In contrast, no significant differ-
ences were observed for TS, WM, and WH, which can
evaluate mainly learning and motor function. These
results suggest that the DFAT transplantation by the
current method (intravenous injection) has limited
effects of functional recovery after cerebral infarction.
It was reported that the expressions of neurogenesis,
synaptogenesis, angiogenesis, and oligodendrogenesis
markers such as NF, Olig-2, SYP, and VEGF were
significantly augmented in the brain sections har-
vested after MSC administration (Gutie´rrez-Ferna´n-
dez et al. 2013b). Neurogenesis, synaptogenesis,
Fig. 4 Results from behavioral tests. a In the water maze test
(WM), there was no significant difference between the cerebral
infarction DFAT-transplant and cerebral infarction PBS-admin-
istered groups. b In the hot plate test (HP) at 56 C, there was a
significant difference between the cerebral infarction DFAT-
transplant and the cerebral infarction PBS-administered groups.
c In the wire hang test (WH), there was no significant difference
between the cerebral infarction DFAT-transplant and the
cerebral infarction PBS-administered groups. d In the forced
swimming test (FS) at 1 min, there was a significant difference
between the cerebral infarction DFAT-transplant and the
cerebral infarction PBS-administered groups. e In the tail
suspension test (TS), there was no significant difference
between the cerebral infarction DFAT-transplant and the
cerebral infarction PBS-administered groups. (*P\ 0.05 com-
parison between the cerebral infarction DFAT-transplant group
and the cerebral infarction PBS-administered group. P\ 0.05
comparison between the cerebral infarction DFAT-transplant
group and the sham control group. §P\ 0.05 comparison
between the cerebral infarction PBS-administered group and the
sham control group)
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angiogenesis, and oligodendrogenesis were promoted
by MSC administration, and functional recovery after
cerebral infarction was observed. Because DFAT have
similar characteristic to MSC (Fig. 2), neurogenesis,
synaptogenesis, angiogenesis, and oligodendrogenesis
were promoted by DFAT transplantation, and func-
tional recovery was observed in this study as well.
However, we have not confirmed whether markers
such as NF, Olig-2, SYP, and VEGF are expressed in
the brain sections after DFAT transplantation. In order
to elucidate by what mechanism DFAT promotes
functional recovery, we would like to investigate these
markers in a future study. Since mice in the sham
group did not develop cerebral infarction, we specu-
late that there was no decrease in function, and the
results of behavior tests were better compared with
mice in the PBS-administered group or the DFAT-
transplant group that developed cerebral infarction.
In the current study, we chose intravenous admin-
istration for cell transplantation, because this method
is rather non-invasive for stroke-patient. However,
after intravenous administration, labeled DFAT were
distributed mainly in other organs, such as the spleen
lungs and liver as well as the brain. Although a report
has shown that intravenously administered human
MSC reach their brains (Tfilin et al. 2010), others have
noted that intravenously administered MSC are
retained in the lungs, with a substantially lower
percentage in the brain (Chen et al. 2001; Argibay
et al. 2017). Conversely, a direct approach for
transplantation to reach the affected area has been
reported in studies with a depressed rat model and a
murine spinal cord injury model (Gutie´rrez-Ferna´ndez
et al. 2013a; Chen et al. 2001). They showed that a
sufficient number of cells reached the affected area,
thereby confirming the effectiveness of the transplan-
tation. In light of these reports, we should consider the
method for transplantation other than intravenous
administration, such as intra-arterial or intracerebral
administration in the future.
In summary, we established DFAT from human
buccal adipose pads and found that these cells had
Fig. 5 Changes in cerebral capacity and transplant cell
distribution due to DFAT transplantation. There was a
significant difference between the cerebral infarction DFAT-
transplant group and the sham control group, and between the
cerebral infarction PBS-administered group and the sham
control group in a, c, d, and f. No significant differences were
observed among the three groups in the non-infarct side
(contralateral cortex) (b, e). As a result of cell tracking with a
Vybrant Multicolor Cell-Labeling Kit (Dil), labeled cells were
observed in brain (g), spleen (h), liver (i) and lungs (j). Scale
bar = 25 lm. (P\ 0.01 comparison between the cerebral
infarction DFAT-transplant group and the sham control group.
§§P\ 0.01 comparison between the cerebral infarction PBS-
administered group and the sham control group)
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characteristics similar to MSC in vitro. These cells are
originally expressing neural stem cell markers before
differentiation to mature cells and show neuronal
differentiation with expressing some neural markers.
Although the DFAT transplantation to the mice after
cerebral infarction did not morphologically affect the
post-infarct brain, it appears to improve some brain
function estimated by behavioral tests. These findings
suggest that the DFAT extracted from the patients’
own tissue can be an option for the treatment of
cerebral infarction.
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